Reagents News and Research

RSS

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein purification projects, today announced a €5 million EUR (c.$5.58 million USD) investment into its protein production and biophysical characterization capabilities and services from its parent company, FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies.

From FairJourney Biologics S.A. 8 Mar 2022

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Researchers evaluate the feasibility and robustness of an optimized RT-LAMP SARS-CoV-2 detection assay across multiple resource-restricted settings.

4 Mar 2022

Beckman Coulter Life Sciences launches CellMek SPS, a fully automated sample preparation system for clinical flow cytometry

Beckman Coulter Life Sciences, a global leader in life sciences lab automation and innovation, and a company of Danaher Corporation (NYSE: DHR), introduces a powerful solution to manual sample preparation and data management bottlenecks in clinical flow cytometry: the CellMek SPS. This fully automated sample preparation system (SPS) offers on-demand processing for a multitude of sample types to help laboratories to expand capabilities.

From Beckman Coulter Life Sciences - Flow Cytometry 3 Mar 2022

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

The current study discusses a reliable ELISA that can detect three isotypes of antibody against three SARS-CoV-2 antigens.

2 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

Novel platform can become a potential approach for personalized cancer treatments

Killing cancer cells without affecting surrounding normal cells is the most desirable approach for targeted cancer therapy. However, it cannot be easily achieved due to the similarities in the properties between normal and cancer cells.

22 Feb 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

From Illumina, Inc. 17 Feb 2022

Fortis Life Sciences Highlights First Year Success

Fortis Life Sciences, a strategic platform company providing capital, expertise, and operational resources to grow founder-led life science companies, today announced highlights from its first year of operations.

From Fortis Life Sciences 17 Feb 2022

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

The novel coronavirus, or SARS-CoV-2, which causes the highly contagious COVID-19, has infected millions of people worldwide.

9 Feb 2022

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Researchers evaluate the travel restrictions placed by nations worldwide following the emergence of the SARS-CoV-2 Omicron variant.

2 Feb 2022

Developing post-vaccination SARS-CoV-2 standard reference sera

A new study reports the generation of reference sera reagents that were obtained from subjects vaccinated with one of four COVID-19 vaccines.

1 Feb 2022

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, today reported it has consolidated and integrated its six manufacturing-related acquisitions to achieve a hybrid manufacturing/distribution model providing key benefits to its customers in high-growth end markets including pharmaceuticals, biopharmaceuticals, vaccines, nutraceuticals, agriculture, cosmetics and specialty chemicals.

27 Jan 2022

New, low-cost COVID-19 test could make high-performance testing more accessible

Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.

24 Jan 2022

Optical imaging reveals how cancer cells hijack metabolic activity to fuel pancreatic tumor growth

Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.

22 Jan 2022

New study to help understand the effect of cancer medicine

When the muscles become acidic after doing too many press-ups, squats or cycling to work, it is because of lactic acid.

21 Jan 2022

Solidifying its Leadership Position in Clinical Flow Cytometry, Beckman Coulter Life Sciences Receives IVDR Certification Covering More than 200 Flow Cytometry Reagents

Leading the way with the industry’s largest portfolio of CE-IVD labeled flow cytometry reagents in the market, Beckman Coulter Life Sciences announces that it has received a EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for more than 200 flow cytometry reagents developed and manufactured at their Marseille, France facility.

From Beckman Coulter Life Sciences - Flow Cytometry 20 Jan 2022

Reagents News and Research

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

RT-LAMP assay shows promise as point-of-care SARS-CoV-2 detection assay across multiple settings

Beckman Coulter Life Sciences launches CellMek SPS, a fully automated sample preparation system for clinical flow cytometry

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Novel platform can become a potential approach for personalized cancer treatments

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Fortis Life Sciences Highlights First Year Success

New reagent-free SARS-CoV-2 detection technique based on machine learning and Raman spectroscopy

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Developing post-vaccination SARS-CoV-2 standard reference sera

Aceto consolidates acquisition of six manufacturers, strengthening its unique hybrid model that provides major supply chain benefits to customers

New, low-cost COVID-19 test could make high-performance testing more accessible

Optical imaging reveals how cancer cells hijack metabolic activity to fuel pancreatic tumor growth

New study to help understand the effect of cancer medicine

Solidifying its Leadership Position in Clinical Flow Cytometry, Beckman Coulter Life Sciences Receives IVDR Certification Covering More than 200 Flow Cytometry Reagents

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Faster and more affordable method for detecting adulteration of meat products

The Native Antigen Company Expands Range of Norovirus-Like Particles

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News